Nov 21

Antibak - MRSA

Posted by admin

Hospitals across the UK are winning the battle against killer bugs as a result of a breakthough in pathogen eradication. The Chemex Antibak is the only product on the market with the cleaning power to kill Clostridium difficile spores and it has provided the NHS with a powerful new weapon that can open up closed wards at short notice.

Easy to use with a simple spray on and wipe off system, this has been successfully trialled in Berkshire where eight wards were closed due to a Norovirus outbreak. AntiBak was applied in the afternoon and the wards were swabbed the same evening. Tests then showed the wards to be completely clear.  Berkshire Shared Services’ mobile deep clean team has proven AntiBak’s effectiveness against a number of pathogens including C. diff spores.

Daughne Taylor, Head of Operations, Risk and Business Development for Berkshire Shared Services, said: “We were faced with a serious infection outbreak in a number of different patient-related areas, transferred in from areas outside our control. AntiBak gave us fast clear results that enabled us to re-open critical bed space in a far shorter time without compromise to patient safety.
The back up support Chemex offered to all my team and the speed with which they reacted when contacted with our dilemma was second to none. Chemex AntiBak is a safe, effective, easy to use concept which delivers huge rewards and a safe method of working for our front line staff, but more importantly offers our patients peace of mind that we take their health protection seriously.”

In Lincolnshire a ward which had been closed long-term due to Aspergillus infestation at the Pilgrim Hospital in Boston was re-opened after using AntiBak.

Infection Control Nurse Wendy Creasey said: “Our team found AntiBak easy to use with no need for extensive PPE or training. Environmental samples taken post-treatment showed no evidence of any Aspergillus niger.”

Chemex International Director Sean Derrig said AntiBak had now been proven on hospital wards as well as in the laboratory. “This is the first time hospitals have had a cleaning agent that kills C. diff spores which has been proven in independent trials to be 1,000 times more effective than traditional protocols at a fraction of the concentration. “It is neither hypochlorite nor quat-based and is completely non-toxic in use. Its revolutionary chemistry and has none of the Health and Safety dangers of chlorine or peroxide based protocols but is devastatingly effective against pathogens.

“When used to clean wards or operating theatres it does not require the lengthy shutdowns or specialist techniques which are often associated with traditional ‘deep cleans’ and costs less than the disinfectant sprays that you might find in your local supermarket.”

In independent testing AntiBak has achieved the Internationally Approved EN1276, EN13704, EN14476 and EN1650 standards against the spores. It has also achieved veterinary approvals from Defra for use against foot and mouth disease, Avian Flu H5N1 and Salmonella choleraesius.

Mr Derrig added: “The Government has made tackling hospital infection one of its priorities and now we can provide hospitals with the most effective weapon available to help ensure patients are protected from potentially lethal bacteria, viruses and spores.”
Chemex AntiBak is a revolutionary compound independently proven to be devastatingly effective against both Clostridium difficile – the bacterium thought to be responsible for killing more than 4,000 hospital patients a year – and its spores.

Test certificates are available to the Internationally Approved EN1276 and EN13704 standards against the deadly organisms and spores AntiBak kills. AntiBak has also achieved four other international standards including veterinary approvals from DEFRA for use against foot and mouth disease, Avian Flu H5N1 and Salmonella choleraesius.

Leave a Reply

You must be logged in to post a comment.